JPRN-jRCT1080222867
Unknown
未知
Investigation of the safety and efficacy of eszopiclone in insomnia patients
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Eisai Co., Ltd.
- Enrollment
- 3300
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) insomnia patients who did not take eszopiclone before assessment
- •2\) patients who receive assessment by using sleep questionaries
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyEUCTR2004-003807-19-ESMerck & Co Inc.600
Active, not recruiting
Not Applicable
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMixed hyperlipidemiaMedDRA version: 7.0Level: LLTClassification code 10027762EUCTR2004-003807-19-ATMerck, Sharp & Dohme600
Active, not recruiting
Phase 1
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMixed hyperlipidemiaMedDRA version: 7.0 Level: LLT Classification code 10027762EUCTR2004-003807-19-GBMerck Sharp & Dohme Ltd600
Active, not recruiting
Not Applicable
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMixed hyperlipidemiaMedDRA version: 7.0Level: LLTClassification code 10027762EUCTR2004-003807-19-HUMerck & Co., Inc.600
Completed
Not Applicable
The study for beneficial efficacy and safety of ezetimibe in patients with hyper LDL-cholesterolemia associated with diabetes mellitus (DM) including glucose intolerance and non-alcoholic fatty liver disease (NAFLD)non-alcoholic fatty liver disease, diabetes mellitus, hyper LDL-cholesterolemiaJPRN-UMIN000004462Geriatric Medicine, Osaka University Graduate School of Medicine20